Significant haemoglobinopathies: guidelines for screening and diagnosis
British Journal of Haematology, 149, 35–49, doi:10.1111/j.1365-2141.2009.08054.x
How I treat unexplained refractory iron deficiency anemia
Endoscopic gastrointestinal workup fails to establish the cause of iron deficiency anemia (IDA) in a substantial proportion of patients. In patients
Pathophysiology, diagnosis, and treatment of paroxysmal nocturnal hemoglobinuria: a review
Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired disorder of the hematopoietic stem cell that makes blood cells more
Guidelines for Hematopoietic Stem Cell Transplantation (HSCT) in Childhood MDS and JMML for Patients enrolled in EWOG-MDS Studies
These guidelines were established and agreed upon by the EWOG-MDS HSCT Board during a Consensus Conference on October
How I treat the postthrombotic syndrome
The postthrombotic syndrome (PTS) is a chronic complication of deep vein thrombosis (DVT) that imposes significant morbidity, reduces
הכנס השנתי ה-29 של האיגוד הישראלי להמטולוגיה ואונקולוגיה ילדים, מלון גליליון | 26-28.4.18
תכנית מדעית מצורפת
How I treat myelodysplastic syndromes of childhood
Myelodysplastic syndromes (MDSs) are clonal hematopoietic disorders characterized by peripheral cytopenia, ineffective hematopoiesis, and an increased risk of
How I treat type 2B von Willebrand disease
Type 2B von Willebrand disease (VWD) is an inherited bleeding disorder caused by changes in von Willebrand factor (VWF)
How I treat disseminated intravascular coagulation
Disseminated intravascular coagulation (DIC) is a condition characterized by systemic activation of coagulation, potentially leading to thrombotic obstruction of
